Investors

Stock price graph
     

BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders.

View all »   RSSRecent Releases

Apr 3, 2014
BG Medicine, Inc. Prices $10.0 Million Public Offering of Common Stock

Apr 2, 2014
BG Medicine, Inc. Announces Proposed Public Offering of Common Stock